The largest database of trusted experimental protocols
Sourced in United States

RIPK1 is a protein kinase that plays a key role in the regulation of cell death and inflammation pathways. It is involved in the formation of the death-inducing signaling complex (DISC) and the activation of apoptosis and necroptosis. RIPK1 contains a kinase domain and a death domain that are important for its signaling functions.

Automatically generated - may contain errors

13 protocols using ripk1

1

Investigating Cell Death Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagents and sources were as follows: Con A, LPS from Escherichia coli O111:B4, and N-galactosamine (GalN) (Sigma-Aldrich); TNF (Peprotech); α-galactosyl ceramide (α-GalCer, KRN7000) and Mdivi-1 (Enzo Life Sciences); Nec-1s (7-Cl-O-Nec-1, BioVision); FK 506 (LC Labs); cycloheximide (Calbiochem); phospho-ASK1(sc-109911, 1:500 dilution), NFATc2 (sc-7296, 1:1000 dilution), RIPK1 (sc-7881, 1:1000 dilution), RIPK3 (sc-47364, 1:1000 dilution), and HDAC1 (sc-7872, 1:500 dilution) antibodies (Santa Cruz Biotechnology); anti-GAPDH antibody (MAB374, 1:5000 dilution, Chemicon); phospho-p38α (#9211), phospho-JNK (#9251), phospho-ERK (#9101), and phospho-Drp1 (Ser637, #4867) antibodies (1:1000 dilution, Cell Signaling Technology); anti-MLKL antibody (AP14272b, 1:1000 dilution, Abgent); anti-Fas (clone Jo2, #554254, 5 μg per mouse, BD Pharmingen); CD3-FITC (#11-0032, 0.25 μg per 105 cells), CD4-PerCP/Cy5.5 (#35-0042, 0.125 μg per 105 cells), and CD69-PE antibodies (#1-0691, 0.25 μg per 105 cells) (eBioscience); and MitoSOX RED (Molecular Probes). APC-mCD1d/PBS57 ligand tetramers were generously provided by the National Institute of Allergy and Infectious Disease MHC Tetramer Core Facility (Atlanta, GA, USA).
+ Open protocol
+ Expand
2

Autophagy Regulation in Cell Death

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture materials were obtained from Invitrogen and fetal calf serum was from Gibco. 3-bromopyruvate, chloroquine diphosphate, 3-methyladenine (3-MA), 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT), Nec1 were purchased from Sigma-Aldrich. z-VAD-fmk was purchased from Calbiochem. JC-1 and Annexin V-FICT/PI assay were purchased from KeyGEN BioTECH (China). GFP-LC3 plasmid was purchased from GeneCopoeia. The following antibodies were used: LC3, Bclin-1 (MBL), Bax, Bak, Bcl-2, Mcl-1 (ProteinTech), Atg7 (Beyotime), RIPK1 (Santa cruz), RIPK3 (Cell Signaling).
+ Open protocol
+ Expand
3

Eleutheroside B Inhibits Cisplatin-Induced Injury

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eleutheroside B was purchased from Chengdu Herbpurify Biotechnology (2018041701, CAS 118-34-3, Chengdu, China). Cisplatin was purchased from Sigma-Aldrich (Sigma, St. Louis, MO, USA). Lactate dehydrogenase (LDH), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT), and Annexin V-FITC/PI Apoptosis Detection Kit was obtained from Beyotime (Shanghai, China). Periodic acid-Schiff (PAS), Creatinine Assay Kit, BUN Assay Kit, and Malondialdehyde (MDA) Assay Kit were purchased from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine serum (FBS), and other cell culture reagents were obtained from Invitrogen. Antibodies specific to KIM-1, β-actin, RIPK1, and RIPK3 were purchased from Santa Cruz Biotechnology. Anti-P-MLKL and anti-cleaved-caspase3 were obtained from Cell Signaling Technology (CST, Danvers, MA, USA). IRDye 800-conjugated secondary antibody was purchased from Licor (Lincoln, NE, USA).
+ Open protocol
+ Expand
4

Mechanistic Study of Apoptosis Regulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reagents and sources were as follows: Con A, LPS from Escherichia coli O111:B4, and N-galactosamine (GalN) (Sigma-Aldrich); TNF (Peprotech); α-galactosyl ceramide (α-GalCer, KRN7000) and Mdivi-1 (Enzo Life Sciences); Nec-1s (7-Cl-O-Nec-1, BioVision); FK 506 (LC Labs); cycloheximide (Calbiochem); phospho-ASK1(sc-109911, 1:500 dilution), NFATc2 (sc-7296, 1:1,000 dilution), RIPK1 (sc-7881, 1:1,000 dilution), RIPK3 (sc-47364, 1:1,000 dilution), and HDAC1 (sc-7872, 1:500 dilution) antibodies (Santa Cruz Biotechnology); anti-GAPDH antibody (MAB374, 1:5,000 dilution, Chemicon); phospho-p38α (#9211), phospho-JNK (#9251), phospho-ERK (#9101) and phospho-Drp1 (Ser637, #4867) antibodies (1:1,000 dilution, Cell Signaling Technology); anti-MLKL antibody (AP14272b, 1:1,000 dilution, Abgent); anti-Fas (clone Jo2, #554254, 5 μg per mouse, BD Pharmingen); CD3-FITC (#11–0032, 0.25 μg per 105 cells), CD4-PerCP/Cy5.5 (#35–0042, 0.125 μg per 105 cells), and CD69-PE antibodies (#1–0691, 0.25 μg per 105 cells) (eBioscience); and MitoSOX RED (Molecular Probes). APC-mCD1d/PBS57 ligand tetramers were generously provided by the National Institute of Allergy and Infectious Disease MHC Tetramer Core Facility (Atlanta, GA, USA).
+ Open protocol
+ Expand
5

Protein Expression Profiling in Liver Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
With 48‐hr treatments of lactoferrin, three MRPs, and the combinations, the HL‐7702 cells were gathered. And the total protein in cells and in liver tissue samples were extracted using a protein extraction kit (Solarbio) and measured by a BCA kit (Solarbio). After 10 min heat treatment of 95℃, the protein samples were added into the 10% SDS–polyacrylamide gels and the electrophoresis was performed, the proteins were transferred onto nitrocellulose membranes by Trans‐Blot machines (Tanon), and the filters were blocked with 2% BSA in TBST buffer for 1.5 hr at room temperature (RT). Then, the proteins were probed with different primary antibodies for 3 hr at RT, including β‐actin, RIPK‐1, RIPK‐3, MLKL, P‐MLKL, TNF‐α, and IL‐1β (Santa Cruz), respectively. The β‐actin was utilized to promise the equal loadings. After washing with PBST buffer (3 × 10 min), the membranes were incubated with the according secondary antibodies for 1.5 hr at RT and then washed with PBST buffer (4 × 15 min). Finally, the membranes were detected utilizing an ECL reagent and analyzed by Image J software (Rawak Software, Inc.).
+ Open protocol
+ Expand
6

Comprehensive Cell Lysate Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total Cell Lysate was prepared in RIPA (purchased from Boston Bioproducts, Ashland, MA, USA). Measurement of protein concentration, independent of the extraction method, was performed using BCA assay kit from Pierce, Grand Island, NY, USA. SDS-PAGE and immunoblotting was performed using standard protocol. The cell lysates were separated on 10% or 15% glycine SDS-PAGE gel and transferred to PVDF membrane. Membranes were blocked in 5% non-fat dry milk in TBS with 0.1% TWEEN-20 (TBST) for 1 h at room temperature followed by incubation with indicated primary antibodies in TBST with 5% BSA. Antibodies were purchased from following vendors. BMI-1 was from Invitrogen (37-5400), Bethyl Laboratories Montgomery, TX, USA (IHC-00606) and Proteintech, Rosemont, IL, USA (66161); uH2A (8240), H2A (2578), RING1A (2820), LC3B (2775), β-Actin (4970) , PARP (9542), Cleaved Caspase-3 (9664), Cleaved Caspase-7 (8438), Cleaved Caspase-9 (7237), NFkB/p65 (4764) from Cell Signaling Technology (Danvers, MA, USA); RIPK1 (374639) from Santa Cruz Biotechnology (Dallas, TX, USA); XIAP (MAB822) from R&D Systems (Minneapolis, MN, USA) and secondary antibodies conjugated with horseradish peroxidase IgG Rabbit (A6154) and Mouse (A4416) from Sigma–Aldrich . Primary antibodies were used in dilutions recommended by the manufacturer. Secondary antibodies were used at a concentration of 1:10,000.
+ Open protocol
+ Expand
7

Glucocorticoid Receptor Phosphorylation Dynamics

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded with DCC-FBS RPMI media in the presence or absence of CM, treated with Dex/Etop for the indicated times and western blot analysis performed as described previously [36 (link)]. Cells were lysed in high salt lysis buffer and protein concentration was determined using the BioRad assay. Antibodies recognizing actin (Sigma-Aldrich), GR (H300, Santa Cruz Biotechnology), GR phosphorylated at S211 (Abcam), GR phosphorylated at S226 (Abcam), BECN1 (Abcam), RIPK1 (Santa Cruz Biotechnology) and caspase-3 (New England Biolabs) were used. ImageJ was used for quantifying blots [37 (link)].
+ Open protocol
+ Expand
8

Western Blot Analysis of Cellular Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Equal amounts of protein were resolved by SDS-PAGE and transferred to a polyvinylidene difluoride (PVDF) membrane. Antibodies and dilutions used in this study were as follows: 1:2,000 AIP1/ALIX (Millipore), 1:4,000 RIPK1, 1:7,500 hnRNP K (Santa Cruz), 1:1,000 PFAS (abcam), 1:2,000 ACYL (Millipore), 1:1,000 VDP p115/p115 (Novus Biologicals), 1:2,000 p115 (abcam), 1:1,000 GBF1 (abcam), 1:500 α-tubulin (Santa Cruz), 1:3,000 G3BP1 (BD Transduction Science), 1:3,000 VP1 (Dako), 1:2,000 Flag (Sigma-Aldrich), and 1:1,000 PARP (Santa Cruz).
+ Open protocol
+ Expand
9

Western Blot Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protein was extracted using SDS lysis buffer and transferred to PVDF membranes. After the membranes were blocked with 5% skim milk for 1 h, they were incubated with primary antibodies overnight at 4 °C, which was followed by incubation with secondary antibodies for 2 hours. Bands were visualized using a C-Digit Blot Scanner (Gene Company) and analyzed with ImageJ software. GADPH (1:1000, sc-47724, Santa Cruz) was used as a protein loading control. The following primary antibodies were used: antibodies against eIF4E (1:200, sc-9976) from Santa Cruz, RIPK1 (1:500, ab106393), VE-cadherin (1:500, ab33168), vimentin (1:1000, ab92547), and Snail (1:1000, ab180714) from Abcam (Cambridge, USA), phospho-AKT (S473) (1:500, T40067F) from Abmart, AKT (1:500, #AF6259) from Affinity, E-cadherin (1:1000, #3195) from Cell Signaling Technology, and MMP-2 (1:500, 10373-2-AP) from Proteintech.
+ Open protocol
+ Expand
10

Modulating Cell Death Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Commercially available siRNA targeting RIPK1, RIPK3, MLKL, caspase-1, caspase-2, caspase-4, caspase-8 and caspase-10 (Santa Cruz, Dallas, TX) were used to transfect A549 alveolar epithelial cells following the manufacturer instructions. Commercially available CRISPR-Cas9 plasmids to knock out MLKL (Santa Cruz, Dallas, TX) were used following the manufacturer instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!